In late February, 2018, the U.S. National Institutes of Health (NIH) announced that the institute is funding two studies on behalf of the National Institute of Health's (NIH) National Drug Effectiveness Program (NDAEP) that will test two Cannabidiol products for dogs with epilepsy. The two drugs, which are currently under study, are being evaluated to provide treatment options for seizure disorders in animals. Both products, Mitoxantrone and Caffeine Valium, are currently under clinical trials. Both projects are part of the larger NDAEP program, the Clinical and Translational Study of Drug Research (CTCR). Read more here about the top CBD products to look out for. In late February, it was reported that the UK's National Health Service (NHS) is funding two further studies on behalf of the NHS' National Health Service (NHS) for the use of cannabidiol for pets. According to the press release, "The first study is investigating the effect of cannabidiol on behavior in dogs with obsessive-compulsive disorder." The second project is investigating "the effect of cannabidiol on the anxiety and depression in elderly Alzheimer's disease patients." While both studies are still ongoing, the National Institutes of Health (NIH) released statements claiming that the work is moving forward at a good pace and that the two studies are expected to be released prior to the end of summer. Both projects have a cost of nearly three hundred thousand pounds. Many people who live with pets, along with their owners, are concerned about the numerous health issues that can arise from the use of pharmaceutical drugs and other medications. For example, many prescription and over-the-counter treatments (OTC) for anxiety issues include the use of benzodiazepines, antidepressants, or other tranquilizers which can have harmful side effects. Similarly, some common canine diseases, such as arthritis and flea infestations, respond well to the administration of oral antihistamines. In order to provide a viable treatment option for pets suffering from anxiety and depression, researchers at the University of Glasgow in the UK have developed an all-natural, homeopathic remedy that can be used in addition to conventional therapies. The results of this study have been published in the peer-reviewed Journal of Human Psychology and Criminal Justice. In the report," Cannabidiol in pets: a review of the use of cannabidiol in the treatment of behavioral disorders in animals," the researchers reported that their tests showed that the substance "acted in a way to reduce symptoms of depression and anxiety." They went on to state that further tests are necessary to determine whether the findings are indeed true. Take a look at this website: okoapet.com to get the best CBD products for pets. In order to determine whether or not the results of the tests were based in reality, it would be wise for consumers to consult with their veterinarians or mammal specialists. However, even with the information available, it can be difficult for pet owners to discern which treatment options might be best for their pets. While there are many promising results and testimonials about CBD products for pets, the truth is that the benefits of the substance are still very much in doubt. Veterinarians and other professionals maintain, instead, that the substance has yet to prove its effectiveness for a wide range of ailments. Therefore, it might be best to wait and see what CBD can do for your pet's health before taking the necessary steps of trying it out yourself. For example, CBD oil is formulated in a pharmaceutical manner; this means that the actual dose is much lower than the dose utilized by pharmaceuticals. CBD oil for pets is also not habit-forming like many other habit-forming drugs and does not cause physical dependency. Nevertheless, it can only do so much. You'll have to choose between a CBD product for cats or dogs, CBD pet sprays, and CBD toys - wisely.To get more info about this topic, check out this site: https://en.wikipedia.org/wiki/Hemp.
0 Comments
Leave a Reply. |